التفاصيل البيبلوغرافية
| العنوان: |
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study |
| المؤلفون: |
Wu, Zhi-Ming, Kan, Jing, Ye, Fei, You, Wei, Wu, Xiang-Qi, Tian, Nai-Liang, Lin, Song, Ge, Zhen, Liu, Zhi-Zhong, Li, Xiao-Bo, Gao, Xiao-Fei, Chen, Jing, Wang, Yan, Wen, Shang-Yu, Xie, Ping, Cong, Hong-Liang, Liu, Li-Jun, Zeng, He-Song, Zhou, Lei, Liu, Fan, Zheng, Yong-Hong, Li, Rui, Ji, Hong-Lei, Zhou, Sheng-Hua, Zhao, Shou-Ming, Qian, Xue-Song, Luo, Jun, Wang, Xin, Zhang, Jun-Jie, Chen, Shao-Liang |
| المصدر: |
In American Heart Journal November 2024 277:58-65 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder